R2CHADS2 Score and Thromboembolic Events After Catheter Ablation of Atrial Fibrillation in Comparison With the CHA2DS2-VASc Score

Canadian Journal of Cardiology

Volumn 30, Issue 4, 2014, Pages 405-412

  Chao, Tze Fan ^a,b   Lin, Yenn Jiang ^a,b   Chang, Shih Lin ^a,b   Lo, Li Wei ^a,b   Hu, Yu Feng ^a,b   Tuan, Ta Chuan ^a,b   Liao, Jo Nan ^a,b   Chung, Fa Po ^a,b   Hsieh, Ming Hsiung ^c   Chen, Shih Ann ^a,b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BRAIN ISCHEMIA; CATHETER ABLATION; DIAGNOSTIC ACCURACY; EMBOLISM; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; RENAL DYSFUNCTION CONGESTIVE HEART FAILURE HYPERTENSION AGE DIABETES STROKE TRANSIENT ISCHEMIC ATTACK SCORE; RISK; THROMBOEMBOLISM; TRANSIENT ISCHEMIC ATTACK; AGE; CEREBROVASCULAR ACCIDENT; COMPARATIVE STUDY; DIABETES MELLITUS; HEART FAILURE; HYPERTENSION; KIDNEY FAILURE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; SEX DIFFERENCE; VALIDATION STUDY; VASCULAR DISEASE;

AGE FACTORS; ATRIAL FIBRILLATION; CATHETER ABLATION; DIABETES MELLITUS; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HUMANS; HYPERTENSION; ISCHEMIC ATTACK, TRANSIENT; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RENAL INSUFFICIENCY; RISK ASSESSMENT; ROC CURVE; SEX FACTORS; STROKE; THROMBOEMBOLISM; VASCULAR DISEASES;

EID: 84897038475     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cjca.2014.01.005     Document Type: Article

References (29)

1. Potpara T.S., Lip G.Y. Lone atrial fibrillation: what is known and what is to come. Int J Clin Pract 2011, 65:446-457.
2. Ahmad Y., Lip G.Y., Lane D.A. Recent developments in understanding epidemiology and risk determinants of atrial fibrillation as a cause of stroke. Can J Cardiol 2013, 29:S4-13.
3. Hunter R.J., McCready J., Diab I., et al. Maintenance of sinus rhythm with an ablation strategy in patients with atrial fibrillation is associated with a lower risk of stroke and death. Heart 2012, 98:48-53.
4. Lin Y.J., Chao T.F., Tsao H.M., et al. Successful catheter ablation reduces the risk of cardiovascular events in atrial fibrillation patients with CHA2DS2-VASc risk score of 1 and higher. Europace 2013, 15:676-684.
5. Bunch T.J., May H.T., Bair T.L., et al. Atrial fibrillation ablation patients have long-term stroke rates similar to patients without atrial fibrillation regardless of CHADS2 score. Heart Rhythm 2013, 10:1272-1277.
6. Chao T.F., Lin Y.J., Tsao H.M., et al. CHADS(2) and CHA(2)DS(2)-VASc scores in the prediction of clinical outcomes in patients with atrial fibrillation after catheter ablation. JAm Coll Cardiol 2011, 58:2380-2385.
7. Camm A.J., Lip G.Y., De Caterina R., et al. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Eur Heart J 2012, 33:2719-2747.
8. Piccini J.P., Stevens S.R., Chang Y., et al. Renal dysfunction as a predictor of stroke and systemic embolism in patients with nonvalvular atrial fibrillation: validation of the R(2)CHADS(2) index in the ROCKET AF (Rivaroxaban Once-daily, oral, direct factor Xa inhibition Compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation) and ATRIA (AnTicoagulation and Risk factors In Atrial fibrillation) study cohorts. Circulation 2013, 127:224-232.
9. Lip G.Y., Nieuwlaat R., Pisters R., Lane D.A., Crijns H.J. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest 2010, 137:263-272.
10. Levey A.S., Bosch J.P., Lewis J.B., et al. Amore accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999, 130:461-470.
11. Chao T.F., Ambrose K., Tsao H.M., et al. Relationship between the CHADS(2) score and risk of very late recurrences after catheter ablation of paroxysmal atrial fibrillation. Heart Rhythm 2012, 9:1185-1191.
12. Chao T.F., Tsao H.M., Lin Y.J., et al. Clinical outcome of catheter ablation in patients with nonparoxysmal atrial fibrillation: results of 3-year follow-up. Circ Arrhythm Electrophysiol 2012, 5:514-520.
13. Chang S.L., Tai C.T., Lin Y.J., et al. The efficacy of inducibility and circumferential ablation with pulmonary vein isolation in patients with paroxysmal atrial fibrillation. JCardiovasc Electrophysiol 2007, 18:607-611.
14. Lin Y.J., Tai C.T., Kao T., et al. Consistency of complex fractionated atrial electrograms during atrial fibrillation. Heart Rhythm 2008, 5:406-412.
15. Lin Y.J., Tai C.T., Chang S.L., et al. Efficacy of additional ablation of complex fractionated atrial electrograms for catheter ablation of nonparoxysmal atrial fibrillation. JCardiovasc Electrophysiol 2009, 20:607-615.
16. Camm A.J., Kirchhof P., Lip G.Y., et al. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J 2010, 31:2369-2429.
17. Olesen J.B., Lip G.Y., Hansen M.L., et al. Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study. BMJ 2011, 342:d124.
18. Abu-Assi E., Otero-Ravina F., Allut Vidal G., et al. Comparison of the reliability and validity of four contemporary risk stratification schemes to predict thromboembolism in non-anticoagulated patients with atrial fibrillation. Int J Cardiol 2013, 166:205-209.
19. Chao T.F., Liu C.J., Chen S.J., et al. Atrial fibrillation and the risk of ischemic stroke: does it still matter in patients with a CHA2DS2-VASc score of 0 or 1?. Stroke 2012, 43:2551-2555.
20. Ha A., Healey J.S. The evolving role of stroke prediction schemes for patients with atrial fibrillation. Can J Cardiol 2013, 29:1173-1180.
21. Olesen J.B., Torp-Pedersen C., Hansen M.L., Lip G.Y. The value of the CHA2DS2-VASc score for refining stroke risk stratification in patients with atrial fibrillation with a CHADS2 score 0-1: a nationwide cohort study. Thromb Haemost 2012, 107:1172-1179.
22. Patel M.R., Mahaffey K.W., Garg J., et al. Rivaroxaban vs warfarin in nonvalvular atrial fibrillation. NEngl J Med 2011, 365:883-891.
23. Roldán V., Marin F., Manzano-Fernandez S., et al. Does chronic kidney disease improve the predictive value of the CHADS2 and CHA2DS2-VASc stroke stratification risk scores for atrial fibrillation?. Thromb Haemost 2013, 109:956-960.
24. Apostolakis S., Lane D.A., Banerjee A. Letter by Apostolakis etal regarding article, "renal dysfunction as a predictor of stroke and systemic embolism in patients with nonvalvular atrial fibrillation: validation of the R2CHADS2 index in the ROCKET AF (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation) and ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) study cohorts". Circulation 2013, 128:e171.
25. Bunch T.J., Crandall B.G., Weiss J.P., et al. Patients treated with catheter ablation for atrial fibrillation have long-term rates of death, stroke, and dementia similar to patients without atrial fibrillation. JCardiovasc Electrophysiol 2011, 22:839-845.
26. Kornej J., Hindricks G., Kosiuk J., et al. Renal dysfunction, stroke risk scores (CHADS2, CHA2DS2-VASc, and R2CHADS2), and the risk of TE events after catheter ablation of atrial fibrillation: the Leipzig Heart Center AF Ablation Registry. Circ Arrhythm Electrophysiol 2013, 6:868-874.
27. Olesen J.B., Lip G.Y., Kamper A.L., et al. Stroke and bleeding in atrial fibrillation with chronic kidney disease. NEngl J Med 2012, 367:625-635.
28. Manzano-Fernández S., Cambronero F., Caro-Martinez C., et al. Mild kidney disease as a risk factor for major bleeding in patients with atrial fibrillation undergoing percutaneous coronary stenting. Thromb Haemost 2012, 107:51-58.
29. Vittinghoff E., McCulloch C.E. Relaxing the rule of ten events per variable in logistic and Cox regression. Am J Epidemiol 2007, 165:710-718.